The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982?2001
International Journal of Health Care Finance and Economics · 2005
DOI: 10.1007/s10754-005-6601-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Health Care Finance and Economics, 2005. Verfasst von Frank R Lichtenberg. Beteiligte Einrichtung: Graduate School of Business, Columbia University, National Bureau of Economic Research, 614 Uris Hall, 3022 Broadway, New York, NY 10027, USA. frank.…. Hauptthemen laut MEDLINE: Global Health, Life Tables. Die Arbeit wurde bisher 96-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Graduate School of Business, Columbia University, National Bureau of Economic Research, 614 Uris Hall, 3022 Broadway, New York, NY 10027, USA. frank.lichtenberg@columbia.edu
Zitieren
APA
Lichtenberg, F. R. (2005). The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982?2001. International Journal of Health Care Finance and Economics. https://doi.org/10.1007/s10754-005-6601-7
Vancouver
Lichtenberg FR. The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982?2001. International Journal of Health Care Finance and Economics. 2005. doi:10.1007/s10754-005-6601-7
BibTeX
@article{Lichtenberg2005,
author = {Lichtenberg, Frank R},
title = {The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982?2001},
journal = {International Journal of Health Care Finance and Economics},
year = {2005},
doi = {10.1007/s10754-005-6601-7}
}
EUVIMED